Koers PharmChem, Inc. Other OTC
Aandelen
PCHM
US7171331025
Gezondheidszorgvoorzieningen & -diensten
Omzet 2001 | 43,98 mln. 40,87 mln. | Omzet 2002 | 30,08 mln. 27,96 mln. | Marktkapitalisatie | 1,35 mln. 1,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2001 | -8 mln. -7,43 mln. | Nettowinst (verlies) 2002 | 3 mln. 2,79 mln. | EV/omzet 2001 | 0,37 x |
Nettoschuld 2001 | 10,89 mln. 10,12 mln. | Nettoschuld 2002 | 2,32 mln. 2,16 mln. | EV/omzet 2002 | 0,12 x |
K/w-verhouding 2001 |
-0,66
x | K/w-verhouding 2002 |
0,4
x | Werknemers | - |
Dividendrendement 2001 * |
-
| Dividendrendement 2002 |
-
| Vrij verhandelbaar | 96,52% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shana Veale
DFI | Director of Finance/CFO | - | 01-09-17 |
Douglas Crook
COO | Chief Operating Officer | - | 01-01-97 |
Sales & Marketing | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Tim Eriksen
CHM | Chairman | 55 | 31-08-21 |
James Ford
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,58% | 8,3 mld. | |
+47,25% | 3,78 mld. | |
-8,58% | 2,47 mld. | |
-38,71% | 2,46 mld. | |
-10,06% | 2,31 mld. | |
-5,44% | 1,95 mld. | |
-17,79% | 1,59 mld. | |
-40,78% | 1,21 mld. | |
+6,69% | 1,1 mld. |